What Trastuzumab is ?
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just under the skin.
Common side effects include fever, infection, cough, headache, trouble sleeping, and rash. Other severe side effects include heart failure, allergic reactions, and lung disease. Use during pregnancy may harm the baby. Trastuzumab works by binding to the HER2 receptor and slowing down cell duplication.
Trastuzumab was approved for medical use in the United States in September 1998, and in the European Union in August 2000. It is on the World Health Organization’s List of Essential Medicines. A biosimilar was approved in the European Union in November 2017, and in the United States in December 2018.
What are the Alternate Brands of Trastuzumab?
- Trasmab™ By Aureate Healthcare.
- Herceptin By Genentech
- Hertraz By Mylan
- Eleftha By Intas
- CanMab By Biocon
- Vivitra By Zydus
- Herclon By Roche
- Trasturel By Reliance
- Biceltis By Emucure